Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aplastic anaemia.

Robert A Brodsky1, Richard J Jones

  • 1Johns Hopkins University School of Medicine, Division of Hematology, and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. brodsro@jhmi.edu

Lancet (London, England)
|May 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study.

Haematologica·2026
Same author

PT/Cy-based alloBMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemia.

Blood advances·2026
Same author

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Scientific reports·2026
Same author

Noninvasive Monitoring of Complement Using the Bioluminescent Modified Ham Assay in the Second Porcine-to-Human Live Heart Transplant.

Xenotransplantation·2026
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

Blood advances·2026
Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Aplastic anaemia is a rare stem-cell disorder causing pancytopenia. Immune-mediated destruction of hematopoietic stem cells is the primary cause, with effective treatments including transplantation and immunosuppression.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Aplastic anaemia is a rare, life-threatening disorder of hematopoietic stem cells, characterized by pancytopenia and hypocellular bone marrow.
  • While most cases are acquired and immune-mediated, rare inherited forms exist.
  • The pathophysiology involves autoreactive lymphocytes destroying hematopoietic stem cells, potentially triggered by environmental factors.

Purpose of the Study:

  • To summarize the pathophysiology, clinical course, and treatment of aplastic anaemia.
  • To highlight the links between aplastic anaemia, paroxysmal nocturnal haemoglobinuria, and myelodysplastic syndrome.

Main Methods:

  • Literature review of aplastic anaemia pathophysiology and treatment.
  • Analysis of the immune-mediated mechanisms involved in hematopoietic stem cell destruction.

Related Experiment Videos

  • Review of established and emerging therapeutic strategies.

    • Main Results:

    • Acquired aplastic anaemia is predominantly immune-mediated, with idiopathic cases being most common.
    • The disease course is variable, ranging from mild to life-threatening pancytopenia.
    • Paroxysmal nocturnal haemoglobinuria and myelodysplastic syndrome are common sequelae, indicating shared pathophysiological pathways.

    Conclusions:

    • Effective treatments for acquired aplastic anaemia include allogeneic bone-marrow transplantation, immunosuppression (antithymocyte globulin and ciclosporin), and high-dose cyclophosphamide.
    • Understanding the immune basis is crucial for managing this rare hematologic disorder.